Sun Pharma to shutter Detroit, MI plant; 179 jobs affected
Sun Pharma says the closure of a Michigan plant employing 179 staff is necessary in order to consolidate its US manufacturing network, and not related to its Ranbaxy acquisition.
Sun Pharma says the closure of a Michigan plant employing 179 staff is necessary in order to consolidate its US manufacturing network, and not related to its Ranbaxy acquisition.
No shortage of an FDA approved scorpion anti-venom biopharmaceutical is envisioned after a manufacturing facility in Mexico received a Warning Letter, US distributor Rare Disease Therapeutics says.
WuXi PharmaTech says it has no intention using stainless steel tanks at its new cell therapy manufacturing facility in Philadelphia, Pennsylvania.